Carbidopa 25 MG / levodopa 250 MG Oral Tablet — RxCUI 197445
RxNorm drug concept · Semantic clinical drug
RxCUI 197445
Semantic clinical drug · SCD
● Current RxNorm concept 52 FDA products
138 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197445
Official nameCarbidopa 25 MG / levodopa 250 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asCarbidopa 25 MG / L-DOPA 250 MG Oral Tablet; carbidopa (as carbidopa monohydrate) 25 MG / levodopa 250 MG Oral Tablet
FDA products mapped52
Package NDCs mapped138
Reported Medicaid activity (SDUD)118,903 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Levodopa and Carbidopa: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Levodopa is the medicine that actually works in your brain — it crosses into the brain and gets converted into dopamine, the chemical that Parkinson's disease depletes. The problem...
- What exactly does levodopa and carbidopa do, and why do I need both?
- Generally yes, but the timing and content of your meals can matter. High-protein foods — like large servings of meat, eggs, or dairy — can compete with levodopa for absorption in y...
- Can I eat normally while taking this medication?
🕸️ Concept Web — How Carbidopa 25 MG / levodopa 250 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Carbidopa 25 MG / levodopa 250 MG Oral Tablet
RxCUI 197445 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Carbidopa
2019IN -
Levodopa
6375IN -
Carbidopa / levodopa
103990MIN
-
Carbidopa
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Sinemet
36572BN
-
Sinemet
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Carbidopa / levodopa Oral Tablet
371267SCDF -
Carbidopa / levodopa Oral Product
1155774SCDG -
Carbidopa / levodopa Pill
1155775SCDG -
Carbidopa / levodopa Oral Tablet [Sinemet]
368414SBDF -
Sinemet Oral Product
1183182SBDG -
Sinemet Pill
1183183SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Carbidopa / levodopa Oral Tablet
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Carbidopa 25 MG
315568SCDC -
Levodopa 250 MG
316143SCDC -
Carbidopa 25 MG / levodopa 250 MG Oral Tablet [Sinemet]
724602SBD -
Carbidopa 25 MG / levodopa 250 MG [Sinemet]
724600SBDC
-
Carbidopa 25 MG
Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Carbidopa 25 MG
SCDC · 315568 -
Levodopa 250 MG
SCDC · 316143 -
Carbidopa / levodopa Oral Tablet
SCDF · 371267 -
Carbidopa / levodopa Oral Product
SCDG · 1155774 -
Carbidopa / levodopa Pill
SCDG · 1155775
Brand-Name Concepts
-
Carbidopa 25 MG / levodopa 250 MG Oral Tablet [Sinemet]
SBD · 724602 -
Carbidopa 25 MG / levodopa 250 MG [Sinemet]
SBDC · 724600 -
Carbidopa / levodopa Oral Tablet [Sinemet]
SBDF · 368414 -
Sinemet Oral Product
SBDG · 1183182 -
Sinemet Pill
SBDG · 1183183 -
Sinemet
BN · 36572
📦 FDA Products & Package NDCs
52 products · 138 package NDCs
138 package NDCs map to RxCUI 197445 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 71205-0878-90 | 90 TABLET in 1 BOTTLE, PLASTIC (71205-878-90) | Carbidopa and Levodopa | Proficient Rx LP | 2021-11-05 |
| 71205-0879-00 | 100 TABLET in 1 BOTTLE, PLASTIC (71205-879-00) | Carbidopa and Levodopa | Proficient Rx LP | 2021-11-05 |
| 71205-0879-11 | 1000 TABLET in 1 BOTTLE, PLASTIC (71205-879-11) | Carbidopa and Levodopa | Proficient Rx LP | 2021-11-05 |
| 71205-0879-30 | 30 TABLET in 1 BOTTLE, PLASTIC (71205-879-30) | Carbidopa and Levodopa | Proficient Rx LP | 2021-11-05 |
| 71205-0879-55 | 500 TABLET in 1 BOTTLE, PLASTIC (71205-879-55) | Carbidopa and Levodopa | Proficient Rx LP | 2021-11-05 |
| 71205-0879-60 | 60 TABLET in 1 BOTTLE, PLASTIC (71205-879-60) | Carbidopa and Levodopa | Proficient Rx LP | 2021-11-05 |
| 71205-0879-64 | 240 TABLET in 1 BOTTLE, PLASTIC (71205-879-64) | Carbidopa and Levodopa | Proficient Rx LP | 2021-11-05 |
| 71205-0879-72 | 120 TABLET in 1 BOTTLE, PLASTIC (71205-879-72) | Carbidopa and Levodopa | Proficient Rx LP | 2021-11-05 |
| 71205-0879-78 | 180 TABLET in 1 BOTTLE, PLASTIC (71205-879-78) | Carbidopa and Levodopa | Proficient Rx LP | 2021-11-05 |
| 71205-0879-90 | 90 TABLET in 1 BOTTLE, PLASTIC (71205-879-90) | Carbidopa and Levodopa | Proficient Rx LP | 2021-11-05 |
| 72865-0361-01 | 100 TABLET in 1 BOTTLE (72865-361-01) | CARBIDOPA AND LEVODOPA | XLCare Pharmaceuticals, Inc. | 2026-01-19 |
| 72865-0361-10 | 1000 TABLET in 1 BOTTLE (72865-361-10) | CARBIDOPA AND LEVODOPA | XLCare Pharmaceuticals, Inc. | 2026-01-19 |
| 72865-0362-01 | 100 TABLET in 1 BOTTLE (72865-362-01) | CARBIDOPA AND LEVODOPA | XLCare Pharmaceuticals, Inc. | 2026-01-19 |
| 72865-0362-10 | 1000 TABLET in 1 BOTTLE (72865-362-10) | CARBIDOPA AND LEVODOPA | XLCare Pharmaceuticals, Inc. | 2026-01-19 |
| 72865-0363-01 | 100 TABLET in 1 BOTTLE (72865-363-01) | CARBIDOPA AND LEVODOPA | XLCare Pharmaceuticals, Inc. | 2026-01-19 |
| 72865-0363-10 | 1000 TABLET in 1 BOTTLE (72865-363-10) | CARBIDOPA AND LEVODOPA | XLCare Pharmaceuticals, Inc. | 2026-01-19 |
| 72888-0106-00 | 1000 TABLET in 1 BOTTLE (72888-106-00) | Carbidopa-levodopa | Advagen Pharma Ltd., | 2023-02-01 |
| 72888-0106-01 | 100 TABLET in 1 BOTTLE (72888-106-01) | Carbidopa-levodopa | Advagen Pharma Ltd., | 2023-02-01 |
| 72888-0106-05 | 500 TABLET in 1 BOTTLE (72888-106-05) | Carbidopa-levodopa | Advagen Pharma Ltd., | 2023-02-01 |
| 72888-0106-30 | 30 TABLET in 1 BOTTLE (72888-106-30) | Carbidopa-levodopa | Advagen Pharma Ltd., | 2023-02-01 |
| 72888-0107-00 | 1000 TABLET in 1 BOTTLE (72888-107-00) | Carbidopa-levodopa | Advagen Pharma Ltd., | 2023-04-01 |
| 72888-0107-01 | 100 TABLET in 1 BOTTLE (72888-107-01) | Carbidopa-levodopa | Advagen Pharma Ltd., | 2023-04-01 |
| 72888-0107-05 | 500 TABLET in 1 BOTTLE (72888-107-05) | Carbidopa-levodopa | Advagen Pharma Ltd., | 2023-04-01 |
| 72888-0107-30 | 30 TABLET in 1 BOTTLE (72888-107-30) | Carbidopa-levodopa | Advagen Pharma Ltd., | 2023-04-01 |
| 72888-0108-00 | 1000 TABLET in 1 BOTTLE (72888-108-00) | Carbidopa-levodopa | Advagen Pharma Ltd., | 2023-04-01 |
| 72888-0108-01 | 100 TABLET in 1 BOTTLE (72888-108-01) | Carbidopa-levodopa | Advagen Pharma Ltd., | 2023-04-01 |
| 72888-0108-05 | 500 TABLET in 1 BOTTLE (72888-108-05) | Carbidopa-levodopa | Advagen Pharma Ltd., | 2023-04-01 |
| 72888-0108-30 | 30 TABLET in 1 BOTTLE (72888-108-30) | Carbidopa-levodopa | Advagen Pharma Ltd., | 2023-04-01 |
| 75907-0020-01 | 100 TABLET in 1 BOTTLE (75907-020-01) | Carbidopa and Levodopa | Dr. Reddy's Laboratories Inc | 2024-05-01 |
| 75907-0020-05 | 500 TABLET in 1 BOTTLE (75907-020-05) | Carbidopa and Levodopa | Dr. Reddy's Laboratories Inc | 2024-05-01 |
| 75907-0020-10 | 1000 TABLET in 1 BOTTLE (75907-020-10) | Carbidopa and Levodopa | Dr. Reddy's Laboratories Inc | 2024-05-01 |
| 75907-0021-01 | 100 TABLET in 1 BOTTLE (75907-021-01) | Carbidopa and Levodopa | Dr. Reddy's Laboratories Inc | 2024-05-01 |
| 75907-0021-05 | 500 TABLET in 1 BOTTLE (75907-021-05) | Carbidopa and Levodopa | Dr. Reddy's Laboratories Inc | 2025-03-15 |
| 75907-0022-01 | 100 TABLET in 1 BOTTLE (75907-022-01) | Carbidopa and Levodopa | Dr. Reddy's Laboratories Inc | 2024-05-01 |
| 78206-0166-01 | 100 TABLET in 1 BOTTLE (78206-166-01) | SINEMET | Organon LLC | 2021-06-01 |
| 78206-0167-01 | 100 TABLET in 1 BOTTLE (78206-167-01) | SINEMET | Organon LLC | 2021-06-01 |
| 78206-0168-01 | 100 TABLET in 1 BOTTLE (78206-168-01) | SINEMET | Organon LLC | 2021-06-01 |
| 78206-0190-01 | 100 TABLET in 1 BOTTLE (78206-190-01) | SINEMET | Organon LLC | 2025-02-28 |
Observed labelers:
Proficient Rx LP (27) ·
Advagen Pharma Ltd., (12) ·
ScieGen Pharmaceuticals Inc (12) ·
Sun Pharmaceutical Industries, Inc. (12) ·
Aurobindo Pharma Limited (8) ·
Camber Pharmaceuticals, Inc. (8)
· +14 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.